ICDDR,B exit 2017-2019 ICDDR,B exit 2017-2019 - icddr,b evaluation Center for Diarrhoeal Disease Research, Bangladesh (icddr,b) har inkommit med en ansökan om fortsatt organisationsstöd till genomförandet av organisationens strategiska plan 2015-2018. Under perioden december 2017 - december 2019 kommer Sverige att bidra med ett utfasningsstöd på SEK 21 400 000 för att stödja icddr,b i genomförandet av deras strategiska plan. 400 000 SEK kommer att öronmärkas för en extern utvärdering vid slutet av programmet och 1 000 000 SEK kommer att öronmärkas för specifik myndighetssamverkan med Patentverket. 

icddr,b är ett internationellt forskningsinstitut inom global hälsa med säte i Bangladesh. Institutet har som mål att hitta lösningar på folkhälsoproblem med ett primärt fokus på utsatta kvinnor, män, flickor och pojkar som lever i fattigdom. Sverige har gett stöd till icddr,b sedan 1981, både i form av forskningsstöd och av institutionsstöd. Ambassaden ingår i en givargrupp som består av Canada (Global Affairs), United Kingdom (DfID) och Sverige som tillsammans ger återkoppling till icddr,b om deras verksamhet. Uppföljning och rapportering görs årligen, och givargruppen turas om att finansiera externa rapporter för utvärdering och uppföljning av icddr,b´s kontroll och riskhanteringssystem. 

Den föreslagna insatsens mål är att genom institutionellt stöd skapa möjligheter för icddr,b att implementera den strategiska planen. Planen för 2015-2018 har fokus på följande 6 strategiska mål:

-Implementering av forskningsstrategin inom folkhälsa
-Öka synligheten och effekten av forskningsbevis
-Investering i icddr,b´s forskningsplattformar
-Investering i kunskap och kompetens
-Förbättra organisationens effektivitet and kostnads-effektivitet
-Säkerställa finansiell hållbarhet

Den totala budgeten för icddr,b för 2017 – 2019 är ca 520 000 000 SEK.

Ambassaden avser att stödja implementeringen av den strategiska planen med ett belopp på 20 400 000 SEK.Ambassadens bedömning är att insatsen är relevant i relation till Sveriges resultatstrategi för utvecklingssamarbetet med Bangladesh 2014 - 2020, delresultat 4 om grundläggande hälsa.

English Summary:
During the exit phase Sweden will provide SEK 21 400 000 over the period 2017 - 2019 to support icddr,b in the implementation of the Strategic Plan 2015 - 2018. Sweden has been providing research and core support to icddr,b since 1981 with the aim to ensure that research in health addressed key policy issues for health system in Bangladesh, and that the research findings were communicated to policy users and influenced policy decisions. This objective remains at the core of the Swedish funding during the suggested agreement phase. Core support is suggested as the continued financing modality and it is also suggested to phase out the core support during the 2-year agreement period 2017-2019. Research funding from Sida HQ will continue through an specific agreement for the period 2016-2020 on the amount of MSEK 30,5.

icddr,b has demonstrated the ability to control its own development and preparedness to invest core funds particularly in neglected areas in order to build future capacity. In the coming three years, ambitious efforts are planned to strengthen the capacity of icddr,b with improved monitoring, evaluation and reporting structures and processes as key targets. Achievements in the strategic objectives will be assessed against icddr,b´s framework for results that will track output and outcome indicators to monitor progress. Fiduciary risks have been assessed as high but the internal systems related to financial management have been strengthened during the last years and icddr,b has made rapid progress towards reducing these risks. Through its participation in the Core Donor Group, Sweden together with Canada (Global Affairs) and the United Kingdom (Department for International Development  - DfID) will ensure that the risks in the programme are carefully monitored and managed. An external evaluation will be conducted at the end of the agreement to assess the overall success of the programme. The budget for the evaluation has been allocated and is earmarked in the contribution budget. Exit support to icddr,b 2017-2018. During the exit phase Sweden will provide SEK 21 400 000 over the period 2017 - 2019 to support icddr,b in the implementation of the Strategic Plan 2015 - 2018. Sweden has been providing research and core support to icddr,b since 1981 with the aim to ensure that research in health addressed key policy issues for health system in Bangladesh, and that the research findings were communicated to policy users and influenced policy decisions. This objective remains at the core of the Swedish funding during the suggested agreement phase.

Core support is suggested as the continued financing modality and it is also suggested to phase out the core support during the 2-year agreement period 2017-2019. Research funding from Sida HQ will continue through an specific agreement for the period 2016-2020 on the amount of MSEK 30,5. icddr,b has demonstrated the ability to control its own development and preparedness to invest core funds particularly in neglected areas in order to build future capacity. In the coming three years, ambitious efforts are planned to strengthen the capacity of icddr,b with improved monitoring, evaluation and reporting structures and processes as key targets.

Achievements in the strategic objectives will be assessed against icddr,b´s framework for results that will track output and outcome indicators to monitor progress. Fiduciary risks have been assessed as high but the internal systems related to financial management have been strengthened during the last years and icddr,b has made rapid progress towards reducing these risks. Through its participation in the Core Donor Group, Sweden together with Canada (Global Affairs) and the United Kingdom (Department for International Development - DfID) will ensure that the risks in the programme are carefully monitored and managed. An external evaluation will be conducted at the end of the agreement to assess the overall success of the programme. The budget for the evaluation has been allocated and is earmarked in the contribution budget. This support focuses on strengthening the institutional capacity of icddr,b to implement the Strategic Plan 2015 - 2018 that focuses on six goals:
Goal 1: Implement a focused research strategy.  Goal 2: Increase the visibility of and impact of icddr,b´s research evidence.  Goal 3: Invest in research platforms.  Goal 4: Invest in people.  Goal 5: Improve organizational efficiency and cost-effectiveness.  Goal 6: Ensure financial sustainability.
Sweden has been providing research and core support to icddr,b since 1981 with the aim to ensure that research in health addressed key policy issues for health system in Bangladesh, and that the research findings were communicated to policy users and influenced policy decisions. This objective remained at the core of the Swedish funding during the phase out agreement phase.